Illinois General Assembly

Previous General Assemblies

Full Text of HB5233  97th General Assembly

HB5233sam002 97TH GENERAL ASSEMBLY

Sen. Kwame Raoul

Filed: 4/23/2012

 

 


 

 


 
09700HB5233sam002LRB097 20167 RPM 68732 a

1
AMENDMENT TO HOUSE BILL 5233

2    AMENDMENT NO. ______. Amend House Bill 5233 by replacing
3everything after the enacting clause with the following:
 
4    "Section 5. The Illinois Food, Drug and Cosmetic Act is
5amended by changing Sections 2.4, 3.22, 5, and 6 as follows:
 
6    (410 ILCS 620/2.4)  (from Ch. 56 1/2, par. 502.4)
7    Sec. 2.4. (a) "Drug" means (1) articles recognized in the
8official United States Pharmacopoeia - National Formulary,
9official Homeopathic Pharmacopoeia of the United States,
10United States Dispensatory, or Remington's Practice of
11Pharmacy, or any supplement to any of them; and (2) articles
12intended for use in the diagnosis, cure, mitigation, treatment
13or prevention of disease in man or other animals; and (3)
14articles (other than food) intended to affect the structure or
15any function of the body of man or other animals; and (4)
16articles intended for use as a component of any article

 

 

09700HB5233sam002- 2 -LRB097 20167 RPM 68732 a

1specified in clause (1), (2) or (3); but does not include
2devices or their components, parts or accessories.
3    (b) "Synthetic drug product" means any product that
4contains a substance defined as a controlled substance under
5subsections (d) and (e) of Section 204 of the Illinois
6Controlled Substances Act. Products approved by the U.S. Food
7and Drug Administration for human consumption are not synthetic
8drug products.
9(Source: P.A. 84-891.)
 
10    (410 ILCS 620/3.22)  (from Ch. 56 1/2, par. 503.22)
11    Sec. 3.22. (a) Whoever knowingly distributes, or possesses
12with intent to distribute, human growth hormone for any use in
13humans other than the treatment of a disease or other
14recognized medical condition, where the use has been authorized
15by the Secretary of Health and Human Services and under the
16order of a physician, is guilty of a Class 3 felony, and may be
17fined an amount not to exceed $50,000. As used in this Section,
18the term "human growth hormone" means somatrem, somatropin, or
19an analogue of either of them.
20    (b) Whoever distributes, or possesses with intent to
21distribute, a synthetic drug product or a drug that is
22misbranded under this Act is guilty of a Class 2 felony and may
23be fined an amount not to exceed $100,000. A person convicted
24of a second or subsequent violation of this Section is guilty
25of a Class 1 felony, the fine for which shall not exceed

 

 

09700HB5233sam002- 3 -LRB097 20167 RPM 68732 a

1$250,000.
2    (c) Whoever falsely advertises a synthetic drug product is
3guilty of a Class 3 felony and may be fined an amount not to
4exceed $100,000.
5    (d) Whoever commits any offense set forth in this Section
6and the offense involves an individual under 18 years of age is
7punishable by not more than 10 years imprisonment, and twice
8the fine authorized above. Any conviction for a violation of
9this Section shall be considered a violation of the Illinois
10Controlled Substances Act for the purposes of forfeiture under
11Section 505 of such Act. As used in this Section the term
12"human growth hormone" means somatrem, somatropin, or an
13analogue of either of them. The Department of State Police and
14Department of Professional Regulation are authorized to
15investigate offenses punishable by this Section.
16    (e) Any person convicted under this Section is subject to
17the forfeiture provisions set forth in subsections (c), (d),
18(e), (f), (g), (h), and (i) of Section 3.23 of this Act.
19(Source: P.A. 87-754.)
 
20    (410 ILCS 620/5)  (from Ch. 56 1/2, par. 505)
21    Sec. 5. (a) A person who violates any of the provisions of
22this Act, other than Sections 3.22 and 6, is guilty of a Class
23C misdemeanor; but if the violation is committed after a
24conviction of such person under this Section has become final,
25the person shall be guilty of a Class A misdemeanor. A person

 

 

09700HB5233sam002- 4 -LRB097 20167 RPM 68732 a

1who violates the provisions of Section 6 of this Act is guilty
2of a Class A misdemeanor; but if the violation is committed
3after a conviction of such person under this Section has become
4final, the person shall be guilty of a Class 4 felony.
5    (b) No person is subject to the penalties of subsection (a)
6of this Section for (1) violating Section 3.1 or 3.3 if he
7establishes a guaranty or undertaking signed by and containing
8the name and address of the person residing in the State of
9Illinois from whom he received the article in good faith, to
10the effect that the article is not adulterated or misbranded
11within the meaning of this Act, designating this Act; or (2)
12for having violated clause (2) of Section 3.16 if such person
13acted in good faith and had no reason to believe that the use
14of the punch, die, plate, stone or other thing involved would
15result in a drug being a counterfeit drug, or for having
16violated clause (3) of Section 3.16 if the person doing the act
17or causing it to be done acted in good faith and had no reason
18to believe that the drug was a counterfeit drug.
19    (c) No publisher, radio-broadcast licensee, agency or
20medium for the dissemination of an advertisement, except the
21manufacturer, packer, distributor or seller of the article to
22which a false advertisement relates is liable under this
23Section for the dissemination of such false advertisement
24unless he has refused on the request of the Director to furnish
25the Director the name and post office address of the
26manufacturer, packer, distributor, seller or advertising

 

 

09700HB5233sam002- 5 -LRB097 20167 RPM 68732 a

1agency residing in the State of Illinois who causes him to
2disseminate such advertisement.
3    (d) No person shall be subject to the penalties of
4subsection (a) of this Section for a violation of Section 3
5involving misbranded food if the violation exists solely
6because the food is misbranded under subsection (c) of Section
711 because of its advertising, and no person shall be subject
8to the penalties of subsection (a) of this Section for such a
9violation unless the violation is committed with the intent to
10defraud or mislead.
11(Source: P.A. 86-704; 87-754.)
 
12    (410 ILCS 620/6)  (from Ch. 56 1/2, par. 506)
13    Sec. 6. (a) When an authorized agent of the Director finds
14or has probable cause to believe that any food, drug, device or
15cosmetic is adulterated or so misbranded as to be dangerous or
16fraudulent within the meaning of this Act, or is in violation
17of Section 12, 17 or 17.1 of this Act, or is suspected to be a
18synthetic drug product, he or she shall affix to such article a
19tag or other appropriate marking giving notice that the article
20is or is suspected of being adulterated or misbranded and has
21been detained or embargoed and warning all persons not to
22remove or dispose of such article by sale or otherwise until
23permission for removal or disposal is given by such agent or
24the court. It is unlawful for any person to remove or dispose
25of such detained or embargoed article by sale or otherwise

 

 

09700HB5233sam002- 6 -LRB097 20167 RPM 68732 a

1without such permission.
2    (b) When an article detained or embargoed under subsection
3(a) of this Section is found by such agent to be adulterated or
4misbranded or to be in violation of Section 12, 17 or 17.1 of
5this Act or is suspected to be a synthetic drug product, he or
6she shall petition the circuit court in whose jurisdiction the
7article is detained or embargoed for a libel for condemnation
8of such article. When such agent finds that an article so
9detained or embargoed is not adulterated or misbranded or is
10not a synthetic drug product, he or she shall remove the tag or
11other marking.
12    (c) If the court finds that a detained or embargoed article
13is adulterated or misbranded, such article shall, after entry
14of the judgment, be destroyed at the expense of the claimant
15thereof, under the supervision of such agent, and all court
16costs and fees, and storage and other proper expenses, shall be
17taxed against the claimant of such article or his or her agent.
18However, when the adulteration or misbranding can be corrected
19by proper labeling or processing of the article, the court,
20after entry of the judgment and after such costs, fees and
21expenses have been paid and a good and sufficient bond,
22conditioned that such article shall be so labeled or processed,
23has been executed, may by order direct that such article be
24delivered to the claimant thereof for such labeling or
25processing under the supervision of an agent of the Director.
26The expense of such supervision shall be paid by the claimant.

 

 

09700HB5233sam002- 7 -LRB097 20167 RPM 68732 a

1The article shall be returned to the claimant and the bond
2shall be discharged on the representation to the court by the
3Director that the article is no longer in violation of this
4Act, and that the expenses of such supervision have been paid.
5    (d) Whenever the Director or any of his or her authorized
6agents finds in any room, building, vehicle of transportation
7or other structure, any meat, sea food, poultry, vegetable,
8fruit or other perishable articles which contain any filthy,
9decomposed or putrid substance, or that may be poisonous or
10deleterious to health or otherwise unsafe, the same being
11hereby declared to be a nuisance, the Director or his or her
12authorized agent shall condemn or destroy the same, or in any
13other manner render the same unusable as human food.
14(Source: P.A. 85-564.)
 
15    Section 10. The Illinois Controlled Substances Act is
16amended by changing Section 204 as follows:
 
17    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
18    Sec. 204. (a) The controlled substances listed in this
19Section are included in Schedule I.
20    (b) Unless specifically excepted or unless listed in
21another schedule, any of the following opiates, including their
22isomers, esters, ethers, salts, and salts of isomers, esters,
23and ethers, whenever the existence of such isomers, esters,
24ethers and salts is possible within the specific chemical

 

 

09700HB5233sam002- 8 -LRB097 20167 RPM 68732 a

1designation:
2        (1) Acetylmethadol;
3        (1.1) Acetyl-alpha-methylfentanyl
4    (N-[1-(1-methyl-2-phenethyl)-
5    4-piperidinyl]-N-phenylacetamide);
6        (2) Allylprodine;
7        (3) Alphacetylmethadol, except
8    levo-alphacetylmethadol (also known as levo-alpha-
9    acetylmethadol, levomethadyl acetate, or LAAM);
10        (4) Alphameprodine;
11        (5) Alphamethadol;
12        (6) Alpha-methylfentanyl
13    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
14    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
15    propanilido) piperidine;
16        (6.1) Alpha-methylthiofentanyl
17    (N-[1-methyl-2-(2-thienyl)ethyl-
18    4-piperidinyl]-N-phenylpropanamide);
19        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
20        (7.1) PEPAP
21    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
22        (8) Benzethidine;
23        (9) Betacetylmethadol;
24        (9.1) Beta-hydroxyfentanyl
25    (N-[1-(2-hydroxy-2-phenethyl)-
26    4-piperidinyl]-N-phenylpropanamide);

 

 

09700HB5233sam002- 9 -LRB097 20167 RPM 68732 a

1        (10) Betameprodine;
2        (11) Betamethadol;
3        (12) Betaprodine;
4        (13) Clonitazene;
5        (14) Dextromoramide;
6        (15) Diampromide;
7        (16) Diethylthiambutene;
8        (17) Difenoxin;
9        (18) Dimenoxadol;
10        (19) Dimepheptanol;
11        (20) Dimethylthiambutene;
12        (21) Dioxaphetylbutyrate;
13        (22) Dipipanone;
14        (23) Ethylmethylthiambutene;
15        (24) Etonitazene;
16        (25) Etoxeridine;
17        (26) Furethidine;
18        (27) Hydroxpethidine;
19        (28) Ketobemidone;
20        (29) Levomoramide;
21        (30) Levophenacylmorphan;
22        (31) 3-Methylfentanyl
23    (N-[3-methyl-1-(2-phenylethyl)-
24    4-piperidyl]-N-phenylpropanamide);
25        (31.1) 3-Methylthiofentanyl
26    (N-[(3-methyl-1-(2-thienyl)ethyl-

 

 

09700HB5233sam002- 10 -LRB097 20167 RPM 68732 a

1    4-piperidinyl]-N-phenylpropanamide);
2        (32) Morpheridine;
3        (33) Noracymethadol;
4        (34) Norlevorphanol;
5        (35) Normethadone;
6        (36) Norpipanone;
7        (36.1) Para-fluorofentanyl
8    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
9    4-piperidinyl]propanamide);
10        (37) Phenadoxone;
11        (38) Phenampromide;
12        (39) Phenomorphan;
13        (40) Phenoperidine;
14        (41) Piritramide;
15        (42) Proheptazine;
16        (43) Properidine;
17        (44) Propiram;
18        (45) Racemoramide;
19        (45.1) Thiofentanyl
20    (N-phenyl-N-[1-(2-thienyl)ethyl-
21    4-piperidinyl]-propanamide);
22        (46) Tilidine;
23        (47) Trimeperidine;
24        (48) Beta-hydroxy-3-methylfentanyl (other name:
25    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
26    N-phenylpropanamide).

 

 

09700HB5233sam002- 11 -LRB097 20167 RPM 68732 a

1    (c) Unless specifically excepted or unless listed in
2another schedule, any of the following opium derivatives, its
3salts, isomers and salts of isomers, whenever the existence of
4such salts, isomers and salts of isomers is possible within the
5specific chemical designation:
6        (1) Acetorphine;
7        (2) Acetyldihydrocodeine;
8        (3) Benzylmorphine;
9        (4) Codeine methylbromide;
10        (5) Codeine-N-Oxide;
11        (6) Cyprenorphine;
12        (7) Desomorphine;
13        (8) Diacetyldihydromorphine (Dihydroheroin);
14        (9) Dihydromorphine;
15        (10) Drotebanol;
16        (11) Etorphine (except hydrochloride salt);
17        (12) Heroin;
18        (13) Hydromorphinol;
19        (14) Methyldesorphine;
20        (15) Methyldihydromorphine;
21        (16) Morphine methylbromide;
22        (17) Morphine methylsulfonate;
23        (18) Morphine-N-Oxide;
24        (19) Myrophine;
25        (20) Nicocodeine;
26        (21) Nicomorphine;

 

 

09700HB5233sam002- 12 -LRB097 20167 RPM 68732 a

1        (22) Normorphine;
2        (23) Pholcodine;
3        (24) Thebacon.
4    (d) Unless specifically excepted or unless listed in
5another schedule, any material, compound, mixture, or
6preparation which contains any quantity of the following
7hallucinogenic substances, or which contains any of its salts,
8isomers and salts of isomers, whenever the existence of such
9salts, isomers, and salts of isomers is possible within the
10specific chemical designation (for the purposes of this
11paragraph only, the term "isomer" includes the optical,
12position and geometric isomers):
13        (1) 3,4-methylenedioxyamphetamine
14    (alpha-methyl,3,4-methylenedioxyphenethylamine,
15    methylenedioxyamphetamine, MDA);
16        (1.1) Alpha-ethyltryptamine
17    (some trade or other names: etryptamine;
18    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
19    3-(2-aminobutyl)indole; a-ET; and AET);
20        (2) 3,4-methylenedioxymethamphetamine (MDMA);
21        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
22    (also known as: N-ethyl-alpha-methyl-
23    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
24    and MDEA);
25        (2.2) N-Benzylpiperazine (BZP);
26        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);

 

 

09700HB5233sam002- 13 -LRB097 20167 RPM 68732 a

1        (4) 3,4,5-trimethoxyamphetamine (TMA);
2        (5) (Blank);
3        (6) Diethyltryptamine (DET);
4        (7) Dimethyltryptamine (DMT);
5        (7.1) 5-Methoxy-diallyltryptamine;
6        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
7        (9) Ibogaine  (some trade and other names:
8    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
9    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
10    indole; Tabernanthe iboga);
11        (10) Lysergic acid diethylamide;
12        (10.1) Salvinorin A;
13        (10.5) Salvia divinorum (meaning all parts of the plant
14    presently classified botanically as Salvia divinorum,
15    whether growing or not, the seeds thereof, any extract from
16    any part of that plant, and every compound, manufacture,
17    salts, isomers, and salts of isomers whenever the existence
18    of such salts, isomers, and salts of isomers is possible
19    within the specific chemical designation, derivative,
20    mixture, or preparation of that plant, its seeds or
21    extracts);
22        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
23        (12) Peyote (meaning all parts of the plant presently
24    classified botanically as Lophophora williamsii Lemaire,
25    whether growing or not, the seeds thereof, any extract from
26    any part of that plant, and every compound, manufacture,

 

 

09700HB5233sam002- 14 -LRB097 20167 RPM 68732 a

1    salts, derivative, mixture, or preparation of that plant,
2    its seeds or extracts);
3        (13) N-ethyl-3-piperidyl benzilate (JB 318);
4        (14) N-methyl-3-piperidyl benzilate;
5        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
6    (also known as N-hydroxy-alpha-methyl-
7    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
8        (15) Parahexyl; some trade or other names:
9    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
10    dibenzo (b,d) pyran; Synhexyl;
11        (16) Psilocybin;
12        (17) Psilocyn;
13        (18) Alpha-methyltryptamine (AMT);
14        (19) 2,5-dimethoxyamphetamine
15    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
16        (20) 4-bromo-2,5-dimethoxyamphetamine
17    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
18    4-bromo-2,5-DMA);
19        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
20    Some trade or other names: 2-(4-bromo-
21    2,5-dimethoxyphenyl)-1-aminoethane;
22    alpha-desmethyl DOB, 2CB, Nexus;
23        (21) 4-methoxyamphetamine
24    (4-methoxy-alpha-methylphenethylamine;
25    paramethoxyamphetamine; PMA);
26        (22) (Blank);

 

 

09700HB5233sam002- 15 -LRB097 20167 RPM 68732 a

1        (23) Ethylamine analog of phencyclidine.
2    Some trade or other names:
3    N-ethyl-1-phenylcyclohexylamine,
4    (1-phenylcyclohexyl) ethylamine,
5    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
6        (24) Pyrrolidine analog of phencyclidine. Some trade
7    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
8    PHP;
9        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
10        (26) 2,5-dimethoxy-4-ethylamphetamine
11    (another name: DOET);
12        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
13    (another name: TCPy);
14        (28) (Blank);
15        (29) Thiophene analog of phencyclidine (some trade
16    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
17    2-thienyl analog of phencyclidine; TPCP; TCP);
18        (30) Bufotenine (some trade or other names:
19    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
20    3-(2-dimethylaminoethyl)-5-indolol;
21    5-hydroxy-N,N-dimethyltryptamine;
22    N,N-dimethylserotonin; mappine);
23        (31)  1-Pentyl-3-(1-naphthoyl)indole 
24    Some trade or other names: JWH-018; 
25        (32) 1-Butyl-3-(1-naphthoyl)indole 
26    Some trade or other names: JWH-073;  

 

 

09700HB5233sam002- 16 -LRB097 20167 RPM 68732 a

1        (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 
2    (2-iodophenyl)methanone 
3    Some trade or other names: AM-694;
4        (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-
5    (2-methyloctan-2-yl)phenol 
6    Some trade or other names: CP 47,497 47, 497
7    and its C6, C8 and C9 homologs;
8        (34.5) (33) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 
9    (2-methyloctan-2-yl)phenol), where side chain n=5;  
10    and homologues where side chain n=4, 6, or 7;  Some  
11    trade or other names: CP 47,497; 
12        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
13    (2-methyloctan-2-yl)-6a,7, 
14    10,10a-tetrahydrobenzo[c]chromen-1-ol
15    Some trade or other names: HU-210; 
16        (35.5) (34) (6aS,10aS)-9-(hydroxymethyl)-6,6- 
17    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
18    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
19    salts, and salts of isomers; Some trade or other  
20    names: HU-210, Dexanabinol; 
21        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
22    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
23    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
24    Some trade or other names: HU-211;
25        (37) (2-methyl-1-propyl-1H-indol-
26    3-yl)-1-naphthalenyl-methanone 

 

 

09700HB5233sam002- 17 -LRB097 20167 RPM 68732 a

1    Some trade or other names: JWH-015;
2        (38) 4-methoxynaphthalen-1-yl-
3    (1-pentylindol-3-yl)methanone 
4    Some trade or other names: JWH-081;
5        (39) (1-Pentyl-3-(4-methyl-1-naphthoyl)indole
6    Some trade or other names: JWH-122;
7        (40) 2-(2-methylphenyl)-1-(1-pentyl-
8    1H-indol-3-yl)-ethanone 
9    Some trade or other names: JWH-251;
10        (41) 1-(2-cyclohexylethyl)-3- 
11    (2-methoxyphenylacetyl)indole 
12    Some trade or other names: RCS-8, BTW-8 and SR-18; . 
13        (42) (33) Any compound structurally derived from 
14    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
15    (1-naphthyl)methane by substitution at the 
16    nitrogen atom of the indole ring by alkyl, haloalkyl, 
17    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
18    2-(4-morpholinyl)ethyl whether or not further 
19    substituted in the indole ring to any extent, whether 
20    or not substituted in the naphthyl ring to any extent; 
21        (43) (34) Any compound structurally derived from 
22    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
23    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
24    cycloalkylmethyl, cycloalkylethyl or 
25    2-(4-morpholinyl)ethyl, whether or not further 
26    substituted in the pyrrole ring to any extent, whether 

 

 

09700HB5233sam002- 18 -LRB097 20167 RPM 68732 a

1    or not substituted in the naphthyl ring to any extent; 
2        (44) (35) Any compound structurally derived from 
3    1-(1-naphthylmethyl)indene by substitution 
4    at the 3-position of the indene ring by alkyl, haloalkyl, 
5    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
6    2-(4-morpholinyl)ethyl whether or not further 
7    substituted in the indene ring to any extent, whether 
8    or not substituted in the naphthyl ring to any extent; 
9        (45) (36) Any compound structurally derived from 
10    3-phenylacetylindole by substitution at the 
11    nitrogen atom of the indole ring with alkyl, haloalkyl, 
12    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
13    2-(4-morpholinyl)ethyl, whether or not further 
14    substituted in the indole ring to any extent, whether 
15    or not substituted in the phenyl ring to any extent; 
16        (46) (37) Any compound structurally derived from 
17    2-(3-hydroxycyclohexyl)phenol by substitution 
18    at the 5-position of the phenolic ring by alkyl, 
19    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
20    or 2-(4-morpholinyl)ethyl, whether or not substituted 
21    in the cyclohexyl ring to any extent; . 
22        (47) (33) 3,4-Methylenedioxymethcathinone 
23    Some trade or other names: Methylone; 
24        (48) (34) 3,4-Methyenedioxypyrovalerone 
25    Some trade or other names: MDPV; 
26        (49) (35) 4-Methylmethcathinone 

 

 

09700HB5233sam002- 19 -LRB097 20167 RPM 68732 a

1    Some trade or other names: Mephedrone; 
2        (50) (36) 4-methoxymethcathinone; 
3        (51) (37) 4-Fluoromethcathinone; 
4        (52) (38) 3-Fluoromethcathinone; . 
5        (53) (35) 2,5-Dimethoxy-4-(n)-propylthio- 
6    phenethylamine; 
7        (54) (36) 5-Methoxy-N,N-diisopropyltryptamine; . 
8        (55) Pentedrone. 
9    (e) Unless specifically excepted or unless listed in
10another schedule, any material, compound, mixture, or
11preparation which contains any quantity of the following
12substances having a depressant effect on the central nervous
13system, including its salts, isomers, and salts of isomers
14whenever the existence of such salts, isomers, and salts of
15isomers is possible within the specific chemical designation:
16        (1) mecloqualone;
17        (2) methaqualone; and
18        (3) gamma hydroxybutyric acid.
19    (f) Unless specifically excepted or unless listed in
20another schedule, any material, compound, mixture, or
21preparation which contains any quantity of the following
22substances having a stimulant effect on the central nervous
23system, including its salts, isomers, and salts of isomers:
24        (1) Fenethylline;
25        (2) N-ethylamphetamine;
26        (3) Aminorex (some other names:

 

 

09700HB5233sam002- 20 -LRB097 20167 RPM 68732 a

1    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
2    4-5-dihydro-5-phenyl-2-oxazolamine) and its
3    salts, optical isomers, and salts of optical isomers;
4        (4) Methcathinone (some other names:
5    2-methylamino-1-phenylpropan-1-one;
6    Ephedrone; 2-(methylamino)-propiophenone;
7    alpha-(methylamino)propiophenone; N-methylcathinone;
8    methycathinone; Monomethylpropion; UR 1431) and its
9    salts, optical isomers, and salts of optical isomers;
10        (5) Cathinone (some trade or other names:
11    2-aminopropiophenone; alpha-aminopropiophenone;
12    2-amino-1-phenyl-propanone; norephedrone);
13        (6) N,N-dimethylamphetamine (also known as:
14    N,N-alpha-trimethyl-benzeneethanamine;
15    N,N-alpha-trimethylphenethylamine);
16        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
17    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
18        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
19    (g) Temporary listing of substances subject to emergency
20scheduling. Any material, compound, mixture, or preparation
21that contains any quantity of the following substances:
22        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
23    (benzylfentanyl), its optical isomers, isomers, salts,
24    and salts of isomers;
25        (2) N-[1(2-thienyl)
26   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),

 

 

09700HB5233sam002- 21 -LRB097 20167 RPM 68732 a

1   its optical isomers, salts, and salts of isomers.
2(Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11;
397-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff.
47-22-11; 97-334, eff. 1-1-12; revised 9-14-11.)
 
5    Section 15. The Drug Paraphernalia Control Act is amended
6by changing Section 2 as follows:
 
7    (720 ILCS 600/2)  (from Ch. 56 1/2, par. 2102)
8    Sec. 2. As used in this Act, unless the context otherwise
9requires:
10    (a) The term "cannabis" shall have the meaning ascribed to
11it in Section 3 of the Cannabis Control Act, as if that
12definition were incorporated herein.
13    (b) The term "controlled substance" shall have the meaning
14ascribed to it in Section 102 of the Illinois Controlled
15Substances Act, as if that definition were incorporated herein.
16    (c) "Deliver" or "delivery" means the actual, constructive
17or attempted transfer of possession, with or without
18consideration, whether or not there is an agency relationship.
19    (d) "Drug paraphernalia" means all equipment, products and
20materials of any kind, other than methamphetamine
21manufacturing materials as defined in Section 10 of the
22Methamphetamine Control and Community Protection Act, which
23are intended to be used unlawfully in planting, propagating,
24cultivating, growing, harvesting, manufacturing, compounding,

 

 

09700HB5233sam002- 22 -LRB097 20167 RPM 68732 a

1converting, producing, processing, preparing, testing,
2analyzing, packaging, repackaging, storing, containing,
3concealing, injecting, ingesting, inhaling or otherwise
4introducing into the human body cannabis or a controlled
5substance in violation of the Cannabis Control Act, the
6Illinois Controlled Substances Act, or the Methamphetamine
7Control and Community Protection Act or a synthetic drug
8product or misbranded drug in violation of the Illinois Food,
9Drug and Cosmetic Act. It includes, but is not limited to:
10        (1) kits intended to be used unlawfully in
11    manufacturing, compounding, converting, producing,
12    processing or preparing cannabis or a controlled
13    substance;
14        (2) isomerization devices intended to be used
15    unlawfully in increasing the potency of any species of
16    plant which is cannabis or a controlled substance;
17        (3) testing equipment intended to be used unlawfully in
18    a private home for identifying or in analyzing the
19    strength, effectiveness or purity of cannabis or
20    controlled substances;
21        (4) diluents and adulterants intended to be used
22    unlawfully for cutting cannabis or a controlled substance
23    by private persons;
24        (5) objects intended to be used unlawfully in
25    ingesting, inhaling, or otherwise introducing cannabis,
26    cocaine, hashish, or hashish oil, or a synthetic drug

 

 

09700HB5233sam002- 23 -LRB097 20167 RPM 68732 a

1    product or misbranded drug in violation of the Illinois
2    Food, Drug and Cosmetic Act into the human body including,
3    where applicable, the following items:
4            (A) water pipes;
5            (B) carburetion tubes and devices;
6            (C) smoking and carburetion masks;
7            (D) miniature cocaine spoons and cocaine vials;
8            (E) carburetor pipes;
9            (F) electric pipes;
10            (G) air-driven pipes;
11            (H) chillums;
12            (I) bongs;
13            (J) ice pipes or chillers;
14        (6) any item whose purpose, as announced or described
15    by the seller, is for use in violation of this Act.
16(Source: P.A. 93-526, eff. 8-12-03; 94-556, eff. 9-11-05.)
 
17    Section 99. Effective date. This Act takes effect upon
18becoming law.".